Advertisements


INmune Bio, Inc. Reports Third Quarter 2019 Financial Results and Provides Shareholder Update

LA JOLLA, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the "Company"), an immunology company developing treatments that harness the patien.....»»

Category: earningsSource: benzingaNov 8th, 2019

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2019 Financial Results

Strengthened management team with the appointment of Nicole Rusaw as Chief Financial Officer Cash and cash equivalents of CAD$20.3 million as of July .....»»

Category: earningsSource: benzingaOct 2nd, 2019

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results

SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (NASDAQ:VIR), a clinical-stage immunology company fo.....»»

Category: earningsSource: benzinga17 hr. 55 min. ago

Anchiano Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

CAMBRIDGE, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (NASDAQ:ANCN) ("Anchiano"), a biopharmaceutical company focused on discovery and development of novel therapies to treat cancer, today reported financial result.....»»

Category: earningsSource: benzingaNov 15th, 2019

NuCana Reports Third Quarter 2019 Financial Results and Provides Business Update

Opens Phase III Global Biliar.....»»

Category: earningsSource: benzingaNov 13th, 2019

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results.....»»

Category: earningsSource: benzingaNov 13th, 2019

Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

 -- Reported Positive Topline Results from Pivotal Phase 3 URIROX-1 Trial.....»»

Category: earningsSource: benzingaNov 13th, 2019

Milestone Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Corporate Update

– NODE-301 topline data r.....»»

Category: earningsSource: benzingaNov 13th, 2019

Milestone Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Corporate Update

– NODE-301 topline data readout expected in .....»»

Category: earningsSource: benzingaNov 13th, 2019

Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update

Top-line generic product revenue of $4.7 million in the third quarter.....»»

Category: earningsSource: benzingaNov 13th, 2019

Matinas BioPharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

– Initiated pre-screeni.....»»

Category: earningsSource: benzingaNov 13th, 2019

IDEAYA Biosciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASD.....»»

Category: earningsSource: benzingaNov 13th, 2019

Catalyst Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

- Firdapse® Launch Momentum Continues with Q3 Net Revenues of $30.9 Million -Third Quarter GAAP Net Income of $13.6 Million -Catalyst Provides Net Revenue Guidance – Approximately $100 Mil.....»»

Category: earningsSource: benzingaNov 12th, 2019

Celldex Provides Corporate Update and Reports Third Quarter 2019 Results

HAMPTON, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2019. "Celldex achieved a significant milestone last week.....»»

Category: earningsSource: benzingaNov 12th, 2019

SCYNEXIS Reports Third Quarter 2019 Financial Results and Provides Company Update

JERSEY CITY, N.J., Nov. 12, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today reported financial results for the .....»»

Category: earningsSource: benzingaNov 12th, 2019

TG Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results

TG Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results.....»»

Category: earningsSource: benzingaNov 12th, 2019

Phio Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

Phio Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaNov 12th, 2019

Diffusion Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

.....»»

Category: earningsSource: benzingaNov 11th, 2019

Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update.....»»

Category: earningsSource: benzingaNov 11th, 2019

BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update

TEL AVIV, Israel, Nov. 11, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX.....»»

Category: earningsSource: benzingaNov 11th, 2019

Enbridge Inc. Reports Strong Third Quarter 2019 Results

CALGARY, Nov. 8, 2019 /PRNewswire/ - Enbridge Inc. (Enbridge or the Company) (TSX:ENB) (NYSE:ENB) today reported third quarter 2019 financial results and provided a quarterly business update. THIRD QUARTER 2019 HIGHLIGHTS(.....»»

Category: earningsSource: benzingaNov 8th, 2019